Dr. Reddy’s ends Novartis India brand distribution deal | RDY SEC Filing
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER…
Dr Reddy’s ends distribution deal with Novartis India after ownership change
Dr Reddy’s Laboratories has terminated its distribution and promotion agreement with Novartis India following a change in the…
Stocks in news: Dr Reddy’s, Adani Green, KIMS, JSW Energy, Nestle India
Markets witnessed a strong rebound on Friday, snapping their recent losing streak amid supportive global cues and easing…
Dr Reddy’s, Nestlé Health Science strengthens presence in diabetes, obesity nutrition space
Celevida GLP+ has been scientifically designed and co-created with leading endocrinologists and diabetologists to address protein gaps and…
Dr. Reddy’s & Nestle Health Science launches Celevida GLP Plus
Celevida GLP+ is available in a 350 g pack across pharmacies, retail outlets, and leading e-commerce platforms. | Photo Credit: Srikrishnan PC Dr…
Dr Reddy’s-Nestlé India JV launches drug to address nutrition gaps and preserving muscle health among diabetic, obesity patients on GLP-1 therapy
Dr. Reddy’s and Nestlé Health Science Ltd., a joint venture between Dr. Reddy’s Laboratories Ltd. and Nestlé India…
Dr. Reddy’s & Nestle Health Science launches Celevida GLP Plus
Celevida GLP+ is available in a 350 g pack across pharmacies, retail outlets, and leading e-commerce platforms. | Photo Credit: Srikrishnan PC Dr…